nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—Parkinson's disease—Clonazepam—epilepsy syndrome	0.134	0.554	CpDpCtD
Memantine—GRIN2A—epilepsy syndrome	0.117	0.468	CbGaD
Memantine—Parkinson's disease—Gabapentin—epilepsy syndrome	0.108	0.446	CpDpCtD
Memantine—GRIN2B—epilepsy syndrome	0.0992	0.398	CbGaD
Memantine—GRIN2A—Felbamate—epilepsy syndrome	0.0641	0.214	CbGbCtD
Memantine—GRIN2B—Felbamate—epilepsy syndrome	0.0641	0.214	CbGbCtD
Memantine—GRIN3A—Felbamate—epilepsy syndrome	0.0426	0.142	CbGbCtD
Memantine—CYP2C19—epilepsy syndrome	0.0332	0.133	CbGaD
Memantine—CYP2A6—Amobarbital—epilepsy syndrome	0.00952	0.0317	CbGbCtD
Memantine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00769	0.0256	CbGbCtD
Memantine—CYP2A6—Propofol—epilepsy syndrome	0.0071	0.0237	CbGbCtD
Memantine—CYP2A6—Phenobarbital—epilepsy syndrome	0.00678	0.0226	CbGbCtD
Memantine—CYP2B6—Clobazam—epilepsy syndrome	0.00666	0.0222	CbGbCtD
Memantine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00559	0.0186	CbGbCtD
Memantine—CYP2B6—Carbamazepine—epilepsy syndrome	0.00552	0.0184	CbGbCtD
Memantine—CYP2C19—Felbamate—epilepsy syndrome	0.00519	0.0173	CbGbCtD
Memantine—CYP2C19—Trimethadione—epilepsy syndrome	0.00519	0.0173	CbGbCtD
Memantine—CYP2B6—Primidone—epilepsy syndrome	0.00516	0.0172	CbGbCtD
Memantine—CYP2A6—Valproic Acid—epilepsy syndrome	0.00507	0.0169	CbGbCtD
Memantine—CYP2B6—Phenytoin—epilepsy syndrome	0.00495	0.0165	CbGbCtD
Memantine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00488	0.0163	CbGbCtD
Memantine—CYP2B6—Propofol—epilepsy syndrome	0.00462	0.0154	CbGbCtD
Memantine—CYP2B6—Phenobarbital—epilepsy syndrome	0.00441	0.0147	CbGbCtD
Memantine—CYP2B6—Midazolam—epilepsy syndrome	0.00435	0.0145	CbGbCtD
Memantine—CYP2C19—Clobazam—epilepsy syndrome	0.00423	0.0141	CbGbCtD
Memantine—CYP2B6—Diazepam—epilepsy syndrome	0.00419	0.0139	CbGbCtD
Memantine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00351	0.0117	CbGbCtD
Memantine—CYP2B6—Valproic Acid—epilepsy syndrome	0.0033	0.011	CbGbCtD
Memantine—CYP2C19—Primidone—epilepsy syndrome	0.00328	0.0109	CbGbCtD
Memantine—CYP2C19—Phenytoin—epilepsy syndrome	0.00315	0.0105	CbGbCtD
Memantine—CYP2C19—Propofol—epilepsy syndrome	0.00294	0.00978	CbGbCtD
Memantine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00281	0.00935	CbGbCtD
Memantine—CYP2C19—Diazepam—epilepsy syndrome	0.00266	0.00886	CbGbCtD
Memantine—CYP2C19—Zonisamide—epilepsy syndrome	0.0026	0.00865	CbGbCtD
Memantine—GRIN1—telencephalic ventricle—epilepsy syndrome	0.00221	0.0687	CbGeAlD
Memantine—GRIN2B—telencephalic ventricle—epilepsy syndrome	0.00211	0.0655	CbGeAlD
Memantine—CYP2C19—Valproic Acid—epilepsy syndrome	0.0021	0.00699	CbGbCtD
Memantine—HTR3A—vagus nerve—epilepsy syndrome	0.00198	0.0613	CbGeAlD
Memantine—CYP2C19—Topiramate—epilepsy syndrome	0.00189	0.0063	CbGbCtD
Memantine—GRIN1—ganglion—epilepsy syndrome	0.00138	0.0428	CbGeAlD
Memantine—GRIN2B—ganglion—epilepsy syndrome	0.00131	0.0408	CbGeAlD
Memantine—GRIN2A—ganglion—epilepsy syndrome	0.00115	0.0357	CbGeAlD
Memantine—GRIN1—hindbrain—epilepsy syndrome	0.00105	0.0324	CbGeAlD
Memantine—GRIN2B—hindbrain—epilepsy syndrome	0.000997	0.0309	CbGeAlD
Memantine—GRIN2A—hindbrain—epilepsy syndrome	0.000872	0.027	CbGeAlD
Memantine—HTR3A—ganglion—epilepsy syndrome	0.000762	0.0236	CbGeAlD
Memantine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000749	0.0232	CbGeAlD
Memantine—GRIN3A—forebrain—epilepsy syndrome	0.00061	0.0189	CbGeAlD
Memantine—GRIN1—brainstem—epilepsy syndrome	0.000599	0.0186	CbGeAlD
Memantine—GRIN1—forebrain—epilepsy syndrome	0.000578	0.0179	CbGeAlD
Memantine—GRIN2B—brainstem—epilepsy syndrome	0.000572	0.0177	CbGeAlD
Memantine—GRIN3A—telencephalon—epilepsy syndrome	0.000561	0.0174	CbGeAlD
Memantine—GRIN2B—forebrain—epilepsy syndrome	0.000552	0.0171	CbGeAlD
Memantine—GRIN1—telencephalon—epilepsy syndrome	0.000532	0.0165	CbGeAlD
Memantine—GRIN2B—telencephalon—epilepsy syndrome	0.000507	0.0157	CbGeAlD
Memantine—GRIN2A—brainstem—epilepsy syndrome	0.0005	0.0155	CbGeAlD
Memantine—GRIN2A—forebrain—epilepsy syndrome	0.000482	0.015	CbGeAlD
Memantine—DRD2—ganglion—epilepsy syndrome	0.000466	0.0145	CbGeAlD
Memantine—GRIN2A—telencephalon—epilepsy syndrome	0.000443	0.0138	CbGeAlD
Memantine—GRIN1—midbrain—epilepsy syndrome	0.000382	0.0118	CbGeAlD
Memantine—GRIN1—spinal cord—epilepsy syndrome	0.000372	0.0116	CbGeAlD
Memantine—GRIN2B—spinal cord—epilepsy syndrome	0.000355	0.011	CbGeAlD
Memantine—DRD2—hindbrain—epilepsy syndrome	0.000354	0.011	CbGeAlD
Memantine—GRIN3A—head—epilepsy syndrome	0.000349	0.0108	CbGeAlD
Memantine—GRIN2A—medulla oblongata—epilepsy syndrome	0.000348	0.0108	CbGeAlD
Memantine—HTR3A—brainstem—epilepsy syndrome	0.000331	0.0103	CbGeAlD
Memantine—GRIN3A—nervous system—epilepsy syndrome	0.000331	0.0103	CbGeAlD
Memantine—GRIN1—head—epilepsy syndrome	0.000331	0.0103	CbGeAlD
Memantine—HTR3A—forebrain—epilepsy syndrome	0.00032	0.00992	CbGeAlD
Memantine—GRIN3A—central nervous system—epilepsy syndrome	0.000319	0.00989	CbGeAlD
Memantine—GRIN2A—midbrain—epilepsy syndrome	0.000318	0.00988	CbGeAlD
Memantine—GRIN2B—head—epilepsy syndrome	0.000316	0.0098	CbGeAlD
Memantine—GRIN1—nervous system—epilepsy syndrome	0.000314	0.00974	CbGeAlD
Memantine—GRIN2A—spinal cord—epilepsy syndrome	0.000311	0.00964	CbGeAlD
Memantine—GRIN1—central nervous system—epilepsy syndrome	0.000302	0.00937	CbGeAlD
Memantine—GRIN2B—nervous system—epilepsy syndrome	0.000299	0.00929	CbGeAlD
Memantine—GRIN1—cerebellum—epilepsy syndrome	0.000295	0.00916	CbGeAlD
Memantine—HTR3A—telencephalon—epilepsy syndrome	0.000294	0.00912	CbGeAlD
Memantine—GRIN2B—central nervous system—epilepsy syndrome	0.000288	0.00894	CbGeAlD
Memantine—GRIN2B—cerebellum—epilepsy syndrome	0.000282	0.00874	CbGeAlD
Memantine—GRIN2A—head—epilepsy syndrome	0.000276	0.00856	CbGeAlD
Memantine—GRIN2A—nervous system—epilepsy syndrome	0.000262	0.00812	CbGeAlD
Memantine—GRIN3A—brain—epilepsy syndrome	0.000253	0.00785	CbGeAlD
Memantine—GRIN2A—central nervous system—epilepsy syndrome	0.000252	0.00782	CbGeAlD
Memantine—GRIN2A—cerebellum—epilepsy syndrome	0.000246	0.00764	CbGeAlD
Memantine—GRIN1—brain—epilepsy syndrome	0.00024	0.00744	CbGeAlD
Memantine—GRIN2B—brain—epilepsy syndrome	0.000229	0.0071	CbGeAlD
Memantine—DRD2—brainstem—epilepsy syndrome	0.000203	0.00629	CbGeAlD
Memantine—GRIN2A—brain—epilepsy syndrome	0.0002	0.00621	CbGeAlD
Memantine—DRD2—forebrain—epilepsy syndrome	0.000196	0.00607	CbGeAlD
Memantine—HTR3A—head—epilepsy syndrome	0.000183	0.00568	CbGeAlD
Memantine—DRD2—telencephalon—epilepsy syndrome	0.00018	0.00558	CbGeAlD
Memantine—HTR3A—nervous system—epilepsy syndrome	0.000174	0.00538	CbGeAlD
Memantine—HTR3A—central nervous system—epilepsy syndrome	0.000167	0.00518	CbGeAlD
Memantine—CYP2A6—cerebellum—epilepsy syndrome	0.00016	0.00498	CbGeAlD
Memantine—HTR3A—brain—epilepsy syndrome	0.000133	0.00411	CbGeAlD
Memantine—CYP2A6—brain—epilepsy syndrome	0.00013	0.00404	CbGeAlD
Memantine—DRD2—midbrain—epilepsy syndrome	0.000129	0.00401	CbGeAlD
Memantine—DRD2—head—epilepsy syndrome	0.000112	0.00347	CbGeAlD
Memantine—DRD2—nervous system—epilepsy syndrome	0.000106	0.00329	CbGeAlD
Memantine—DRD2—central nervous system—epilepsy syndrome	0.000102	0.00317	CbGeAlD
Memantine—DRD2—cerebellum—epilepsy syndrome	9.99e-05	0.0031	CbGeAlD
Memantine—CYP2B6—head—epilepsy syndrome	9.05e-05	0.00281	CbGeAlD
Memantine—CYP2B6—nervous system—epilepsy syndrome	8.58e-05	0.00266	CbGeAlD
Memantine—CYP2B6—central nervous system—epilepsy syndrome	8.26e-05	0.00256	CbGeAlD
Memantine—DRD2—brain—epilepsy syndrome	8.11e-05	0.00252	CbGeAlD
Memantine—CYP2B6—brain—epilepsy syndrome	6.56e-05	0.00204	CbGeAlD
Memantine—Ill-defined disorder—Gabapentin—epilepsy syndrome	1.07e-05	9.27e-05	CcSEcCtD
Memantine—Dizziness—Zonisamide—epilepsy syndrome	1.07e-05	9.26e-05	CcSEcCtD
Memantine—Headache—Diazepam—epilepsy syndrome	1.07e-05	9.26e-05	CcSEcCtD
Memantine—Anxiety—Pregabalin—epilepsy syndrome	1.06e-05	9.24e-05	CcSEcCtD
Memantine—Diarrhoea—Clonazepam—epilepsy syndrome	1.06e-05	9.24e-05	CcSEcCtD
Memantine—Anaemia—Gabapentin—epilepsy syndrome	1.06e-05	9.23e-05	CcSEcCtD
Memantine—Hypotension—Valproic Acid—epilepsy syndrome	1.06e-05	9.19e-05	CcSEcCtD
Memantine—Asthenia—Carbamazepine—epilepsy syndrome	1.06e-05	9.19e-05	CcSEcCtD
Memantine—Agitation—Gabapentin—epilepsy syndrome	1.06e-05	9.18e-05	CcSEcCtD
Memantine—Diarrhoea—Phenytoin—epilepsy syndrome	1.06e-05	9.18e-05	CcSEcCtD
Memantine—Discomfort—Pregabalin—epilepsy syndrome	1.05e-05	9.16e-05	CcSEcCtD
Memantine—Nausea—Fosphenytoin—epilepsy syndrome	1.05e-05	9.15e-05	CcSEcCtD
Memantine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	1.05e-05	9.13e-05	CcSEcCtD
Memantine—Erythema multiforme—Topiramate—epilepsy syndrome	1.05e-05	9.13e-05	CcSEcCtD
Memantine—Hypersensitivity—Lamotrigine—epilepsy syndrome	1.05e-05	9.12e-05	CcSEcCtD
Memantine—Vomiting—Felbamate—epilepsy syndrome	1.05e-05	9.1e-05	CcSEcCtD
Memantine—Dry mouth—Pregabalin—epilepsy syndrome	1.04e-05	9.07e-05	CcSEcCtD
Memantine—Pruritus—Carbamazepine—epilepsy syndrome	1.04e-05	9.06e-05	CcSEcCtD
Memantine—Rash—Felbamate—epilepsy syndrome	1.04e-05	9.02e-05	CcSEcCtD
Memantine—Eye disorder—Topiramate—epilepsy syndrome	1.04e-05	9.02e-05	CcSEcCtD
Memantine—Dermatitis—Felbamate—epilepsy syndrome	1.04e-05	9.02e-05	CcSEcCtD
Memantine—Malaise—Gabapentin—epilepsy syndrome	1.04e-05	9.01e-05	CcSEcCtD
Memantine—Tinnitus—Topiramate—epilepsy syndrome	1.04e-05	9e-05	CcSEcCtD
Memantine—Vertigo—Gabapentin—epilepsy syndrome	1.03e-05	8.97e-05	CcSEcCtD
Memantine—Headache—Felbamate—epilepsy syndrome	1.03e-05	8.97e-05	CcSEcCtD
Memantine—Confusional state—Pregabalin—epilepsy syndrome	1.03e-05	8.96e-05	CcSEcCtD
Memantine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	1.03e-05	8.96e-05	CcSEcCtD
Memantine—Cardiac disorder—Topiramate—epilepsy syndrome	1.03e-05	8.96e-05	CcSEcCtD
Memantine—Flushing—Topiramate—epilepsy syndrome	1.03e-05	8.96e-05	CcSEcCtD
Memantine—Syncope—Gabapentin—epilepsy syndrome	1.03e-05	8.96e-05	CcSEcCtD
Memantine—Leukopenia—Gabapentin—epilepsy syndrome	1.03e-05	8.94e-05	CcSEcCtD
Memantine—Dizziness—Clonazepam—epilepsy syndrome	1.03e-05	8.93e-05	CcSEcCtD
Memantine—Nausea—Vigabatrin—epilepsy syndrome	1.03e-05	8.92e-05	CcSEcCtD
Memantine—Vomiting—Zonisamide—epilepsy syndrome	1.02e-05	8.91e-05	CcSEcCtD
Memantine—Insomnia—Valproic Acid—epilepsy syndrome	1.02e-05	8.89e-05	CcSEcCtD
Memantine—Oedema—Pregabalin—epilepsy syndrome	1.02e-05	8.89e-05	CcSEcCtD
Memantine—Asthenia—Lamotrigine—epilepsy syndrome	1.02e-05	8.88e-05	CcSEcCtD
Memantine—Dizziness—Phenytoin—epilepsy syndrome	1.02e-05	8.87e-05	CcSEcCtD
Memantine—Rash—Zonisamide—epilepsy syndrome	1.02e-05	8.83e-05	CcSEcCtD
Memantine—Infection—Pregabalin—epilepsy syndrome	1.02e-05	8.83e-05	CcSEcCtD
Memantine—Paraesthesia—Valproic Acid—epilepsy syndrome	1.02e-05	8.83e-05	CcSEcCtD
Memantine—Palpitations—Gabapentin—epilepsy syndrome	1.02e-05	8.83e-05	CcSEcCtD
Memantine—Dermatitis—Zonisamide—epilepsy syndrome	1.02e-05	8.83e-05	CcSEcCtD
Memantine—Dizziness—Oxcarbazepine—epilepsy syndrome	1.01e-05	8.82e-05	CcSEcCtD
Memantine—Nausea—Diazepam—epilepsy syndrome	1.01e-05	8.78e-05	CcSEcCtD
Memantine—Loss of consciousness—Gabapentin—epilepsy syndrome	1.01e-05	8.78e-05	CcSEcCtD
Memantine—Headache—Zonisamide—epilepsy syndrome	1.01e-05	8.78e-05	CcSEcCtD
Memantine—Dyspnoea—Valproic Acid—epilepsy syndrome	1.01e-05	8.77e-05	CcSEcCtD
Memantine—Diarrhoea—Carbamazepine—epilepsy syndrome	1.01e-05	8.76e-05	CcSEcCtD
Memantine—Angiopathy—Topiramate—epilepsy syndrome	1.01e-05	8.76e-05	CcSEcCtD
Memantine—Pruritus—Lamotrigine—epilepsy syndrome	1.01e-05	8.75e-05	CcSEcCtD
Memantine—Shock—Pregabalin—epilepsy syndrome	1.01e-05	8.75e-05	CcSEcCtD
Memantine—Somnolence—Valproic Acid—epilepsy syndrome	1.01e-05	8.74e-05	CcSEcCtD
Memantine—Immune system disorder—Topiramate—epilepsy syndrome	1e-05	8.72e-05	CcSEcCtD
Memantine—Nervous system disorder—Pregabalin—epilepsy syndrome	1e-05	8.72e-05	CcSEcCtD
Memantine—Cough—Gabapentin—epilepsy syndrome	1e-05	8.71e-05	CcSEcCtD
Memantine—Thrombocytopenia—Pregabalin—epilepsy syndrome	1e-05	8.7e-05	CcSEcCtD
Memantine—Mediastinal disorder—Topiramate—epilepsy syndrome	1e-05	8.7e-05	CcSEcCtD
Memantine—Tachycardia—Pregabalin—epilepsy syndrome	9.98e-06	8.68e-05	CcSEcCtD
Memantine—Chills—Topiramate—epilepsy syndrome	9.96e-06	8.66e-05	CcSEcCtD
Memantine—Dyspepsia—Valproic Acid—epilepsy syndrome	9.96e-06	8.65e-05	CcSEcCtD
Memantine—Convulsion—Gabapentin—epilepsy syndrome	9.95e-06	8.65e-05	CcSEcCtD
Memantine—Skin disorder—Pregabalin—epilepsy syndrome	9.93e-06	8.63e-05	CcSEcCtD
Memantine—Hypertension—Gabapentin—epilepsy syndrome	9.92e-06	8.62e-05	CcSEcCtD
Memantine—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.88e-06	8.59e-05	CcSEcCtD
Memantine—Vomiting—Clonazepam—epilepsy syndrome	9.88e-06	8.59e-05	CcSEcCtD
Memantine—Decreased appetite—Valproic Acid—epilepsy syndrome	9.83e-06	8.55e-05	CcSEcCtD
Memantine—Alopecia—Topiramate—epilepsy syndrome	9.81e-06	8.53e-05	CcSEcCtD
Memantine—Vomiting—Phenytoin—epilepsy syndrome	9.81e-06	8.53e-05	CcSEcCtD
Memantine—Rash—Clonazepam—epilepsy syndrome	9.79e-06	8.51e-05	CcSEcCtD
Memantine—Dermatitis—Clonazepam—epilepsy syndrome	9.78e-06	8.51e-05	CcSEcCtD
Memantine—Arthralgia—Gabapentin—epilepsy syndrome	9.78e-06	8.5e-05	CcSEcCtD
Memantine—Chest pain—Gabapentin—epilepsy syndrome	9.78e-06	8.5e-05	CcSEcCtD
Memantine—Myalgia—Gabapentin—epilepsy syndrome	9.78e-06	8.5e-05	CcSEcCtD
Memantine—Nausea—Felbamate—epilepsy syndrome	9.78e-06	8.5e-05	CcSEcCtD
Memantine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.76e-06	8.49e-05	CcSEcCtD
Memantine—Vomiting—Oxcarbazepine—epilepsy syndrome	9.76e-06	8.48e-05	CcSEcCtD
Memantine—Fatigue—Valproic Acid—epilepsy syndrome	9.75e-06	8.48e-05	CcSEcCtD
Memantine—Anxiety—Gabapentin—epilepsy syndrome	9.75e-06	8.47e-05	CcSEcCtD
Memantine—Anorexia—Pregabalin—epilepsy syndrome	9.75e-06	8.47e-05	CcSEcCtD
Memantine—Dizziness—Carbamazepine—epilepsy syndrome	9.74e-06	8.47e-05	CcSEcCtD
Memantine—Diarrhoea—Lamotrigine—epilepsy syndrome	9.74e-06	8.47e-05	CcSEcCtD
Memantine—Headache—Clonazepam—epilepsy syndrome	9.73e-06	8.46e-05	CcSEcCtD
Memantine—Rash—Phenytoin—epilepsy syndrome	9.73e-06	8.46e-05	CcSEcCtD
Memantine—Mental disorder—Topiramate—epilepsy syndrome	9.73e-06	8.46e-05	CcSEcCtD
Memantine—Dermatitis—Phenytoin—epilepsy syndrome	9.72e-06	8.45e-05	CcSEcCtD
Memantine—Rash—Oxcarbazepine—epilepsy syndrome	9.68e-06	8.41e-05	CcSEcCtD
Memantine—Constipation—Valproic Acid—epilepsy syndrome	9.67e-06	8.41e-05	CcSEcCtD
Memantine—Pain—Valproic Acid—epilepsy syndrome	9.67e-06	8.41e-05	CcSEcCtD
Memantine—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.67e-06	8.4e-05	CcSEcCtD
Memantine—Headache—Phenytoin—epilepsy syndrome	9.66e-06	8.4e-05	CcSEcCtD
Memantine—Malnutrition—Topiramate—epilepsy syndrome	9.66e-06	8.4e-05	CcSEcCtD
Memantine—Discomfort—Gabapentin—epilepsy syndrome	9.66e-06	8.4e-05	CcSEcCtD
Memantine—Headache—Oxcarbazepine—epilepsy syndrome	9.61e-06	8.36e-05	CcSEcCtD
Memantine—Nausea—Zonisamide—epilepsy syndrome	9.57e-06	8.32e-05	CcSEcCtD
Memantine—Dry mouth—Gabapentin—epilepsy syndrome	9.57e-06	8.32e-05	CcSEcCtD
Memantine—Hypotension—Pregabalin—epilepsy syndrome	9.55e-06	8.31e-05	CcSEcCtD
Memantine—Flatulence—Topiramate—epilepsy syndrome	9.52e-06	8.28e-05	CcSEcCtD
Memantine—Tension—Topiramate—epilepsy syndrome	9.48e-06	8.25e-05	CcSEcCtD
Memantine—Dysgeusia—Topiramate—epilepsy syndrome	9.46e-06	8.23e-05	CcSEcCtD
Memantine—Confusional state—Gabapentin—epilepsy syndrome	9.45e-06	8.22e-05	CcSEcCtD
Memantine—Dizziness—Lamotrigine—epilepsy syndrome	9.41e-06	8.18e-05	CcSEcCtD
Memantine—Nervousness—Topiramate—epilepsy syndrome	9.39e-06	8.16e-05	CcSEcCtD
Memantine—Oedema—Gabapentin—epilepsy syndrome	9.38e-06	8.15e-05	CcSEcCtD
Memantine—Vomiting—Carbamazepine—epilepsy syndrome	9.36e-06	8.14e-05	CcSEcCtD
Memantine—Back pain—Topiramate—epilepsy syndrome	9.35e-06	8.13e-05	CcSEcCtD
Memantine—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.32e-06	8.1e-05	CcSEcCtD
Memantine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.32e-06	8.1e-05	CcSEcCtD
Memantine—Infection—Gabapentin—epilepsy syndrome	9.31e-06	8.1e-05	CcSEcCtD
Memantine—Rash—Carbamazepine—epilepsy syndrome	9.29e-06	8.07e-05	CcSEcCtD
Memantine—Dermatitis—Carbamazepine—epilepsy syndrome	9.28e-06	8.06e-05	CcSEcCtD
Memantine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.25e-06	8.04e-05	CcSEcCtD
Memantine—Insomnia—Pregabalin—epilepsy syndrome	9.25e-06	8.04e-05	CcSEcCtD
Memantine—Nausea—Clonazepam—epilepsy syndrome	9.23e-06	8.02e-05	CcSEcCtD
Memantine—Headache—Carbamazepine—epilepsy syndrome	9.23e-06	8.02e-05	CcSEcCtD
Memantine—Shock—Gabapentin—epilepsy syndrome	9.22e-06	8.02e-05	CcSEcCtD
Memantine—Nervous system disorder—Gabapentin—epilepsy syndrome	9.19e-06	7.99e-05	CcSEcCtD
Memantine—Paraesthesia—Pregabalin—epilepsy syndrome	9.18e-06	7.98e-05	CcSEcCtD
Memantine—Thrombocytopenia—Gabapentin—epilepsy syndrome	9.18e-06	7.98e-05	CcSEcCtD
Memantine—Nausea—Phenytoin—epilepsy syndrome	9.16e-06	7.97e-05	CcSEcCtD
Memantine—Tachycardia—Gabapentin—epilepsy syndrome	9.15e-06	7.95e-05	CcSEcCtD
Memantine—Dyspnoea—Pregabalin—epilepsy syndrome	9.12e-06	7.92e-05	CcSEcCtD
Memantine—Nausea—Oxcarbazepine—epilepsy syndrome	9.12e-06	7.92e-05	CcSEcCtD
Memantine—Vision blurred—Topiramate—epilepsy syndrome	9.11e-06	7.92e-05	CcSEcCtD
Memantine—Skin disorder—Gabapentin—epilepsy syndrome	9.11e-06	7.92e-05	CcSEcCtD
Memantine—Somnolence—Pregabalin—epilepsy syndrome	9.09e-06	7.9e-05	CcSEcCtD
Memantine—Hyperhidrosis—Gabapentin—epilepsy syndrome	9.06e-06	7.88e-05	CcSEcCtD
Memantine—Tremor—Topiramate—epilepsy syndrome	9.06e-06	7.87e-05	CcSEcCtD
Memantine—Vomiting—Lamotrigine—epilepsy syndrome	9.05e-06	7.87e-05	CcSEcCtD
Memantine—Urticaria—Valproic Acid—epilepsy syndrome	8.98e-06	7.81e-05	CcSEcCtD
Memantine—Rash—Lamotrigine—epilepsy syndrome	8.97e-06	7.8e-05	CcSEcCtD
Memantine—Ill-defined disorder—Topiramate—epilepsy syndrome	8.97e-06	7.8e-05	CcSEcCtD
Memantine—Dermatitis—Lamotrigine—epilepsy syndrome	8.97e-06	7.79e-05	CcSEcCtD
Memantine—Abdominal pain—Valproic Acid—epilepsy syndrome	8.94e-06	7.77e-05	CcSEcCtD
Memantine—Body temperature increased—Valproic Acid—epilepsy syndrome	8.94e-06	7.77e-05	CcSEcCtD
Memantine—Anorexia—Gabapentin—epilepsy syndrome	8.94e-06	7.77e-05	CcSEcCtD
Memantine—Anaemia—Topiramate—epilepsy syndrome	8.93e-06	7.77e-05	CcSEcCtD
Memantine—Headache—Lamotrigine—epilepsy syndrome	8.92e-06	7.75e-05	CcSEcCtD
Memantine—Decreased appetite—Pregabalin—epilepsy syndrome	8.89e-06	7.73e-05	CcSEcCtD
Memantine—Agitation—Topiramate—epilepsy syndrome	8.88e-06	7.72e-05	CcSEcCtD
Memantine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.83e-06	7.67e-05	CcSEcCtD
Memantine—Fatigue—Pregabalin—epilepsy syndrome	8.82e-06	7.66e-05	CcSEcCtD
Memantine—Hypotension—Gabapentin—epilepsy syndrome	8.76e-06	7.62e-05	CcSEcCtD
Memantine—Nausea—Carbamazepine—epilepsy syndrome	8.75e-06	7.6e-05	CcSEcCtD
Memantine—Constipation—Pregabalin—epilepsy syndrome	8.74e-06	7.6e-05	CcSEcCtD
Memantine—Pain—Pregabalin—epilepsy syndrome	8.74e-06	7.6e-05	CcSEcCtD
Memantine—Malaise—Topiramate—epilepsy syndrome	8.72e-06	7.58e-05	CcSEcCtD
Memantine—Vertigo—Topiramate—epilepsy syndrome	8.68e-06	7.55e-05	CcSEcCtD
Memantine—Syncope—Topiramate—epilepsy syndrome	8.67e-06	7.53e-05	CcSEcCtD
Memantine—Leukopenia—Topiramate—epilepsy syndrome	8.65e-06	7.52e-05	CcSEcCtD
Memantine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.54e-06	7.43e-05	CcSEcCtD
Memantine—Palpitations—Topiramate—epilepsy syndrome	8.54e-06	7.43e-05	CcSEcCtD
Memantine—Loss of consciousness—Topiramate—epilepsy syndrome	8.49e-06	7.38e-05	CcSEcCtD
Memantine—Insomnia—Gabapentin—epilepsy syndrome	8.48e-06	7.37e-05	CcSEcCtD
Memantine—Nausea—Lamotrigine—epilepsy syndrome	8.45e-06	7.35e-05	CcSEcCtD
Memantine—Cough—Topiramate—epilepsy syndrome	8.43e-06	7.33e-05	CcSEcCtD
Memantine—Feeling abnormal—Pregabalin—epilepsy syndrome	8.43e-06	7.32e-05	CcSEcCtD
Memantine—Paraesthesia—Gabapentin—epilepsy syndrome	8.42e-06	7.32e-05	CcSEcCtD
Memantine—Convulsion—Topiramate—epilepsy syndrome	8.37e-06	7.28e-05	CcSEcCtD
Memantine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.36e-06	7.27e-05	CcSEcCtD
Memantine—Dyspnoea—Gabapentin—epilepsy syndrome	8.36e-06	7.27e-05	CcSEcCtD
Memantine—Hypertension—Topiramate—epilepsy syndrome	8.34e-06	7.25e-05	CcSEcCtD
Memantine—Somnolence—Gabapentin—epilepsy syndrome	8.33e-06	7.25e-05	CcSEcCtD
Memantine—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.33e-06	7.24e-05	CcSEcCtD
Memantine—Dyspepsia—Gabapentin—epilepsy syndrome	8.25e-06	7.17e-05	CcSEcCtD
Memantine—Myalgia—Topiramate—epilepsy syndrome	8.23e-06	7.15e-05	CcSEcCtD
Memantine—Arthralgia—Topiramate—epilepsy syndrome	8.23e-06	7.15e-05	CcSEcCtD
Memantine—Chest pain—Topiramate—epilepsy syndrome	8.23e-06	7.15e-05	CcSEcCtD
Memantine—Anxiety—Topiramate—epilepsy syndrome	8.2e-06	7.13e-05	CcSEcCtD
Memantine—Decreased appetite—Gabapentin—epilepsy syndrome	8.15e-06	7.09e-05	CcSEcCtD
Memantine—Discomfort—Topiramate—epilepsy syndrome	8.13e-06	7.07e-05	CcSEcCtD
Memantine—Urticaria—Pregabalin—epilepsy syndrome	8.12e-06	7.06e-05	CcSEcCtD
Memantine—Asthenia—Valproic Acid—epilepsy syndrome	8.11e-06	7.05e-05	CcSEcCtD
Memantine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	8.09e-06	7.04e-05	CcSEcCtD
Memantine—Fatigue—Gabapentin—epilepsy syndrome	8.08e-06	7.03e-05	CcSEcCtD
Memantine—Abdominal pain—Pregabalin—epilepsy syndrome	8.08e-06	7.03e-05	CcSEcCtD
Memantine—Body temperature increased—Pregabalin—epilepsy syndrome	8.08e-06	7.03e-05	CcSEcCtD
Memantine—Dry mouth—Topiramate—epilepsy syndrome	8.05e-06	7e-05	CcSEcCtD
Memantine—Pain—Gabapentin—epilepsy syndrome	8.02e-06	6.97e-05	CcSEcCtD
Memantine—Constipation—Gabapentin—epilepsy syndrome	8.02e-06	6.97e-05	CcSEcCtD
Memantine—Pruritus—Valproic Acid—epilepsy syndrome	8e-06	6.96e-05	CcSEcCtD
Memantine—Confusional state—Topiramate—epilepsy syndrome	7.95e-06	6.91e-05	CcSEcCtD
Memantine—Oedema—Topiramate—epilepsy syndrome	7.89e-06	6.86e-05	CcSEcCtD
Memantine—Infection—Topiramate—epilepsy syndrome	7.84e-06	6.81e-05	CcSEcCtD
Memantine—Shock—Topiramate—epilepsy syndrome	7.76e-06	6.75e-05	CcSEcCtD
Memantine—Diarrhoea—Valproic Acid—epilepsy syndrome	7.74e-06	6.73e-05	CcSEcCtD
Memantine—Nervous system disorder—Topiramate—epilepsy syndrome	7.74e-06	6.72e-05	CcSEcCtD
Memantine—Feeling abnormal—Gabapentin—epilepsy syndrome	7.73e-06	6.72e-05	CcSEcCtD
Memantine—Thrombocytopenia—Topiramate—epilepsy syndrome	7.72e-06	6.71e-05	CcSEcCtD
Memantine—Tachycardia—Topiramate—epilepsy syndrome	7.7e-06	6.69e-05	CcSEcCtD
Memantine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.67e-06	6.67e-05	CcSEcCtD
Memantine—Skin disorder—Topiramate—epilepsy syndrome	7.66e-06	6.66e-05	CcSEcCtD
Memantine—Hyperhidrosis—Topiramate—epilepsy syndrome	7.63e-06	6.63e-05	CcSEcCtD
Memantine—Hypersensitivity—Pregabalin—epilepsy syndrome	7.53e-06	6.55e-05	CcSEcCtD
Memantine—Anorexia—Topiramate—epilepsy syndrome	7.52e-06	6.54e-05	CcSEcCtD
Memantine—Dizziness—Valproic Acid—epilepsy syndrome	7.48e-06	6.5e-05	CcSEcCtD
Memantine—Urticaria—Gabapentin—epilepsy syndrome	7.45e-06	6.48e-05	CcSEcCtD
Memantine—Abdominal pain—Gabapentin—epilepsy syndrome	7.41e-06	6.44e-05	CcSEcCtD
Memantine—Body temperature increased—Gabapentin—epilepsy syndrome	7.41e-06	6.44e-05	CcSEcCtD
Memantine—Hypotension—Topiramate—epilepsy syndrome	7.37e-06	6.41e-05	CcSEcCtD
Memantine—Asthenia—Pregabalin—epilepsy syndrome	7.34e-06	6.38e-05	CcSEcCtD
Memantine—Pruritus—Pregabalin—epilepsy syndrome	7.23e-06	6.29e-05	CcSEcCtD
Memantine—Vomiting—Valproic Acid—epilepsy syndrome	7.19e-06	6.25e-05	CcSEcCtD
Memantine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.19e-06	6.25e-05	CcSEcCtD
Memantine—Insomnia—Topiramate—epilepsy syndrome	7.13e-06	6.2e-05	CcSEcCtD
Memantine—Rash—Valproic Acid—epilepsy syndrome	7.13e-06	6.2e-05	CcSEcCtD
Memantine—Dermatitis—Valproic Acid—epilepsy syndrome	7.12e-06	6.19e-05	CcSEcCtD
Memantine—Headache—Valproic Acid—epilepsy syndrome	7.09e-06	6.16e-05	CcSEcCtD
Memantine—Paraesthesia—Topiramate—epilepsy syndrome	7.08e-06	6.16e-05	CcSEcCtD
Memantine—Dyspnoea—Topiramate—epilepsy syndrome	7.03e-06	6.11e-05	CcSEcCtD
Memantine—Somnolence—Topiramate—epilepsy syndrome	7.01e-06	6.1e-05	CcSEcCtD
Memantine—Diarrhoea—Pregabalin—epilepsy syndrome	7e-06	6.08e-05	CcSEcCtD
Memantine—Dyspepsia—Topiramate—epilepsy syndrome	6.94e-06	6.04e-05	CcSEcCtD
Memantine—Hypersensitivity—Gabapentin—epilepsy syndrome	6.91e-06	6.01e-05	CcSEcCtD
Memantine—Decreased appetite—Topiramate—epilepsy syndrome	6.86e-06	5.96e-05	CcSEcCtD
Memantine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.81e-06	5.92e-05	CcSEcCtD
Memantine—Fatigue—Topiramate—epilepsy syndrome	6.8e-06	5.91e-05	CcSEcCtD
Memantine—Dizziness—Pregabalin—epilepsy syndrome	6.76e-06	5.88e-05	CcSEcCtD
Memantine—Pain—Topiramate—epilepsy syndrome	6.75e-06	5.86e-05	CcSEcCtD
Memantine—Constipation—Topiramate—epilepsy syndrome	6.75e-06	5.86e-05	CcSEcCtD
Memantine—Asthenia—Gabapentin—epilepsy syndrome	6.73e-06	5.85e-05	CcSEcCtD
Memantine—Nausea—Valproic Acid—epilepsy syndrome	6.72e-06	5.84e-05	CcSEcCtD
Memantine—Pruritus—Gabapentin—epilepsy syndrome	6.63e-06	5.77e-05	CcSEcCtD
Memantine—Vomiting—Pregabalin—epilepsy syndrome	6.5e-06	5.65e-05	CcSEcCtD
Memantine—Feeling abnormal—Topiramate—epilepsy syndrome	6.5e-06	5.65e-05	CcSEcCtD
Memantine—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.45e-06	5.61e-05	CcSEcCtD
Memantine—Rash—Pregabalin—epilepsy syndrome	6.45e-06	5.6e-05	CcSEcCtD
Memantine—Dermatitis—Pregabalin—epilepsy syndrome	6.44e-06	5.6e-05	CcSEcCtD
Memantine—Diarrhoea—Gabapentin—epilepsy syndrome	6.41e-06	5.58e-05	CcSEcCtD
Memantine—Headache—Pregabalin—epilepsy syndrome	6.41e-06	5.57e-05	CcSEcCtD
Memantine—Urticaria—Topiramate—epilepsy syndrome	6.27e-06	5.45e-05	CcSEcCtD
Memantine—Abdominal pain—Topiramate—epilepsy syndrome	6.24e-06	5.42e-05	CcSEcCtD
Memantine—Body temperature increased—Topiramate—epilepsy syndrome	6.24e-06	5.42e-05	CcSEcCtD
Memantine—Dizziness—Gabapentin—epilepsy syndrome	6.2e-06	5.39e-05	CcSEcCtD
Memantine—Nausea—Pregabalin—epilepsy syndrome	6.07e-06	5.28e-05	CcSEcCtD
Memantine—Vomiting—Gabapentin—epilepsy syndrome	5.96e-06	5.18e-05	CcSEcCtD
Memantine—Rash—Gabapentin—epilepsy syndrome	5.91e-06	5.14e-05	CcSEcCtD
Memantine—Dermatitis—Gabapentin—epilepsy syndrome	5.91e-06	5.13e-05	CcSEcCtD
Memantine—Headache—Gabapentin—epilepsy syndrome	5.87e-06	5.11e-05	CcSEcCtD
Memantine—Hypersensitivity—Topiramate—epilepsy syndrome	5.81e-06	5.05e-05	CcSEcCtD
Memantine—Asthenia—Topiramate—epilepsy syndrome	5.66e-06	4.92e-05	CcSEcCtD
Memantine—Pruritus—Topiramate—epilepsy syndrome	5.58e-06	4.85e-05	CcSEcCtD
Memantine—Nausea—Gabapentin—epilepsy syndrome	5.57e-06	4.84e-05	CcSEcCtD
Memantine—Diarrhoea—Topiramate—epilepsy syndrome	5.4e-06	4.69e-05	CcSEcCtD
Memantine—Dizziness—Topiramate—epilepsy syndrome	5.22e-06	4.53e-05	CcSEcCtD
Memantine—Vomiting—Topiramate—epilepsy syndrome	5.02e-06	4.36e-05	CcSEcCtD
Memantine—Rash—Topiramate—epilepsy syndrome	4.97e-06	4.32e-05	CcSEcCtD
Memantine—Dermatitis—Topiramate—epilepsy syndrome	4.97e-06	4.32e-05	CcSEcCtD
Memantine—Headache—Topiramate—epilepsy syndrome	4.94e-06	4.3e-05	CcSEcCtD
Memantine—Nausea—Topiramate—epilepsy syndrome	4.69e-06	4.07e-05	CcSEcCtD
Memantine—SLC22A2—Metabolism—CHRM3—epilepsy syndrome	3.41e-06	5.52e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NPY—epilepsy syndrome	3.39e-06	5.48e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.39e-06	5.48e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALDH7A1—epilepsy syndrome	3.33e-06	5.4e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CACNA1A—epilepsy syndrome	3.33e-06	5.4e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SSTR3—epilepsy syndrome	3.32e-06	5.38e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL2—epilepsy syndrome	3.27e-06	5.29e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCL3—epilepsy syndrome	3.27e-06	5.29e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CRH—epilepsy syndrome	3.27e-06	5.29e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—OXT—epilepsy syndrome	3.27e-06	5.29e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ST3GAL3—epilepsy syndrome	3.26e-06	5.28e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCR2—epilepsy syndrome	3.25e-06	5.27e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—SST—epilepsy syndrome	3.25e-06	5.27e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.25e-06	5.26e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ADSL—epilepsy syndrome	3.2e-06	5.18e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NEU1—epilepsy syndrome	3.19e-06	5.16e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ATIC—epilepsy syndrome	3.19e-06	5.16e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—UPB1—epilepsy syndrome	3.19e-06	5.16e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.18e-06	5.16e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NPY2R—epilepsy syndrome	3.18e-06	5.16e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SSTR1—epilepsy syndrome	3.18e-06	5.16e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR8—epilepsy syndrome	3.18e-06	5.16e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR9—epilepsy syndrome	3.18e-06	5.16e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.18e-06	5.15e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GLUL—epilepsy syndrome	3.13e-06	5.08e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CHRM3—epilepsy syndrome	3.13e-06	5.07e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—KCNJ11—epilepsy syndrome	3.13e-06	5.07e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GRM3—epilepsy syndrome	3.12e-06	5.06e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GRM4—epilepsy syndrome	3.12e-06	5.06e-05	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—epilepsy syndrome	3.1e-06	5.02e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CACNA1D—epilepsy syndrome	3.08e-06	4.98e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	3.07e-06	4.97e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DUSP4—epilepsy syndrome	3.07e-06	4.96e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SSTR2—epilepsy syndrome	3.07e-06	4.96e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.06e-06	4.95e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.06e-06	4.95e-05	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—epilepsy syndrome	3.02e-06	4.9e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CNR1—epilepsy syndrome	3e-06	4.86e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PLCB1—epilepsy syndrome	2.99e-06	4.84e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GBE1—epilepsy syndrome	2.96e-06	4.8e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	2.96e-06	4.8e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GRM8—epilepsy syndrome	2.96e-06	4.79e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PGF—epilepsy syndrome	2.96e-06	4.79e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—SST—epilepsy syndrome	2.95e-06	4.78e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR2—epilepsy syndrome	2.95e-06	4.78e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—HTR7—epilepsy syndrome	2.93e-06	4.74e-05	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—POMC—epilepsy syndrome	2.9e-06	4.69e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.9e-06	4.69e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.89e-06	4.68e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TXNRD1—epilepsy syndrome	2.88e-06	4.66e-05	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCL2—epilepsy syndrome	2.84e-06	4.59e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—OPRD1—epilepsy syndrome	2.82e-06	4.57e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GNAO1—epilepsy syndrome	2.82e-06	4.57e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AQP1—epilepsy syndrome	2.79e-06	4.52e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT3—epilepsy syndrome	2.79e-06	4.52e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	2.79e-06	4.51e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCG2—epilepsy syndrome	2.78e-06	4.5e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL12—epilepsy syndrome	2.78e-06	4.5e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.78e-06	4.5e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CNR1—epilepsy syndrome	2.73e-06	4.41e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PLCB1—epilepsy syndrome	2.72e-06	4.4e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP2C19—epilepsy syndrome	2.71e-06	4.39e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	2.71e-06	4.39e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR7—epilepsy syndrome	2.71e-06	4.39e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GRM1—epilepsy syndrome	2.71e-06	4.39e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CHRM1—epilepsy syndrome	2.71e-06	4.39e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PDYN—epilepsy syndrome	2.71e-06	4.39e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP11A1—epilepsy syndrome	2.69e-06	4.36e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HTR7—epilepsy syndrome	2.66e-06	4.31e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NT5E—epilepsy syndrome	2.64e-06	4.28e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALAD—epilepsy syndrome	2.64e-06	4.28e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HBEGF—epilepsy syndrome	2.58e-06	4.18e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCG2—epilepsy syndrome	2.55e-06	4.13e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CDC42—epilepsy syndrome	2.55e-06	4.12e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GFAP—epilepsy syndrome	2.55e-06	4.12e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GAL—epilepsy syndrome	2.55e-06	4.12e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT3—epilepsy syndrome	2.53e-06	4.1e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—KCNJ11—epilepsy syndrome	2.53e-06	4.09e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CHRM3—epilepsy syndrome	2.53e-06	4.09e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	2.52e-06	4.08e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	2.52e-06	4.08e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GRM5—epilepsy syndrome	2.52e-06	4.08e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CHRM3—epilepsy syndrome	2.52e-06	4.08e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP2—epilepsy syndrome	2.52e-06	4.08e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP2C19—epilepsy syndrome	2.49e-06	4.03e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP11A1—epilepsy syndrome	2.47e-06	4e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	2.47e-06	3.99e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AVP—epilepsy syndrome	2.47e-06	3.99e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	2.43e-06	3.94e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ADSL—epilepsy syndrome	2.42e-06	3.91e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CX3CR1—epilepsy syndrome	2.41e-06	3.91e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GLUL—epilepsy syndrome	2.37e-06	3.84e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CX3CL1—epilepsy syndrome	2.37e-06	3.83e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CHRM2—epilepsy syndrome	2.37e-06	3.83e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BDKRB1—epilepsy syndrome	2.37e-06	3.83e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	2.33e-06	3.77e-05	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.32e-06	3.75e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	2.31e-06	3.75e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CDC42—epilepsy syndrome	2.31e-06	3.74e-05	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—epilepsy syndrome	2.31e-06	3.74e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—BCHE—epilepsy syndrome	2.3e-06	3.73e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GABBR1—epilepsy syndrome	2.3e-06	3.73e-05	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—epilepsy syndrome	2.25e-06	3.64e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AVP—epilepsy syndrome	2.24e-06	3.63e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	2.23e-06	3.61e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRH3—epilepsy syndrome	2.21e-06	3.57e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	2.2e-06	3.56e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	2.17e-06	3.52e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	2.17e-06	3.52e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—OPRM1—epilepsy syndrome	2.17e-06	3.52e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TH—epilepsy syndrome	2.17e-06	3.51e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	2.12e-06	3.44e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—BCHE—epilepsy syndrome	2.12e-06	3.43e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AQP1—epilepsy syndrome	2.11e-06	3.42e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCR5—epilepsy syndrome	2.1e-06	3.39e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	2.06e-06	3.34e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR3—epilepsy syndrome	2.05e-06	3.32e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.05e-06	3.32e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.03e-06	3.28e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	2.02e-06	3.27e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	2.01e-06	3.25e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NPY—epilepsy syndrome	2e-06	3.24e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ATP2A2—epilepsy syndrome	2e-06	3.24e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	2e-06	3.23e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	1.99e-06	3.23e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TH—epilepsy syndrome	1.99e-06	3.22e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AGT—epilepsy syndrome	1.95e-06	3.15e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HSPB1—epilepsy syndrome	1.93e-06	3.12e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CRH—epilepsy syndrome	1.93e-06	3.12e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—OXT—epilepsy syndrome	1.93e-06	3.12e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL3—epilepsy syndrome	1.93e-06	3.12e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL2—epilepsy syndrome	1.93e-06	3.12e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	1.91e-06	3.09e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	1.91e-06	3.09e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR5—epilepsy syndrome	1.9e-06	3.08e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.86e-06	3.02e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	1.81e-06	2.93e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	1.8e-06	2.92e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.8e-06	2.91e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TSC1—epilepsy syndrome	1.79e-06	2.9e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTK2B—epilepsy syndrome	1.79e-06	2.9e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CAT—epilepsy syndrome	1.78e-06	2.89e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.78e-06	2.88e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AGT—epilepsy syndrome	1.77e-06	2.86e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR2—epilepsy syndrome	1.75e-06	2.83e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SST—epilepsy syndrome	1.75e-06	2.83e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NTRK2—epilepsy syndrome	1.75e-06	2.83e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.74e-06	2.82e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	1.74e-06	2.81e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DUSP6—epilepsy syndrome	1.73e-06	2.8e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	1.71e-06	2.78e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.71e-06	2.77e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BCHE—epilepsy syndrome	1.71e-06	2.76e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PLAT—epilepsy syndrome	1.7e-06	2.75e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	1.66e-06	2.69e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.64e-06	2.66e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL12—epilepsy syndrome	1.64e-06	2.66e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—POMC—epilepsy syndrome	1.64e-06	2.65e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CAT—epilepsy syndrome	1.64e-06	2.65e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.63e-06	2.64e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	1.63e-06	2.64e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.63e-06	2.63e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GPX1—epilepsy syndrome	1.61e-06	2.61e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	1.61e-06	2.61e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CNR1—epilepsy syndrome	1.61e-06	2.61e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JUNB—epilepsy syndrome	1.61e-06	2.61e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TH—epilepsy syndrome	1.6e-06	2.6e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PLCB1—epilepsy syndrome	1.6e-06	2.6e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	1.59e-06	2.58e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	1.57e-06	2.54e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.56e-06	2.52e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	1.53e-06	2.47e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.51e-06	2.44e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	1.5e-06	2.42e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.5e-06	2.42e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	1.49e-06	2.41e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GPX1—epilepsy syndrome	1.48e-06	2.4e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	1.46e-06	2.37e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	1.46e-06	2.36e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AGT—epilepsy syndrome	1.41e-06	2.29e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOE—epilepsy syndrome	1.39e-06	2.24e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—S100B—epilepsy syndrome	1.38e-06	2.24e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	1.37e-06	2.22e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	1.37e-06	2.21e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.36e-06	2.21e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.36e-06	2.2e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.34e-06	2.17e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AVP—epilepsy syndrome	1.32e-06	2.14e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.32e-06	2.14e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AGT—epilepsy syndrome	1.3e-06	2.1e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.3e-06	2.1e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.29e-06	2.09e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.29e-06	2.08e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOE—epilepsy syndrome	1.27e-06	2.06e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HES1—epilepsy syndrome	1.25e-06	2.03e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.23e-06	1.99e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.22e-06	1.97e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FYN—epilepsy syndrome	1.22e-06	1.97e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TH—epilepsy syndrome	1.21e-06	1.96e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	1.21e-06	1.96e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	1.21e-06	1.96e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.2e-06	1.94e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.19e-06	1.93e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—POMC—epilepsy syndrome	1.19e-06	1.93e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.17e-06	1.89e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NGF—epilepsy syndrome	1.16e-06	1.87e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	1.12e-06	1.82e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	1.1e-06	1.78e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—POMC—epilepsy syndrome	1.09e-06	1.77e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALB—epilepsy syndrome	1.09e-06	1.76e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.05e-06	1.7e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	1.05e-06	1.69e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	1.04e-06	1.69e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.03e-06	1.66e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	1.02e-06	1.66e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.01e-06	1.64e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	1e-06	1.62e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CAT—epilepsy syndrome	9.99e-07	1.62e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALB—epilepsy syndrome	9.97e-07	1.61e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	9.71e-07	1.57e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	9.65e-07	1.56e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	9.61e-07	1.56e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	9.5e-07	1.54e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	9.03e-07	1.46e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—POMC—epilepsy syndrome	8.82e-07	1.43e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	8.79e-07	1.42e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	8.72e-07	1.41e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	8.6e-07	1.39e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALB—epilepsy syndrome	8.04e-07	1.3e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AGT—epilepsy syndrome	7.92e-07	1.28e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	7.77e-07	1.26e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOE—epilepsy syndrome	7.76e-07	1.26e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	7.21e-07	1.17e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	7.07e-07	1.15e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	7.04e-07	1.14e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—POMC—epilepsy syndrome	6.67e-07	1.08e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.57e-07	1.06e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	6.51e-07	1.05e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	6.32e-07	1.02e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	6.15e-07	9.96e-06	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALB—epilepsy syndrome	6.08e-07	9.84e-06	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	5.96e-07	9.66e-06	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	5.67e-07	9.18e-06	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	5.52e-07	8.94e-06	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	5.32e-07	8.61e-06	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—epilepsy syndrome	4.77e-07	7.73e-06	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—epilepsy syndrome	4.38e-07	7.1e-06	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	3.54e-07	5.73e-06	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	3.52e-07	5.7e-06	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.67e-07	4.33e-06	CbGpPWpGaD
